Influenza vaccine in the elderly and chronic obstructive pulmonary disease

Current Infectious Disease Reports

Volumn 7, Issue 3, 2005, Pages 200-203

  Lupatkin, Helene ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; VIRUS RNA;

AGED; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; GERIATRIC CARE; HEART DISEASE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT; MORBIDITY; MORTALITY; NONHUMAN; RESPIRATORY TRACT DISEASE; REVIEW; RNA VIRUS; SIDE EFFECT; UNITED STATES; VIRUS STRAIN;

EID: 19144366749     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0035-8     Document Type: Review

References (26)

1. Centers for Disease Control and Prevention: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2004, 53:1-44.
2. Thompson WW, Shay DK, Weintraub E, et al.: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
3. US Department of Health and Human Services: Healthy People 2010: Understanding and Improving Health, edn 2. Washington DC: US Government Printing Office; 2000.
4. Edwards KM, Dupont WD, Westrich MK, et al.: A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994, 169:68-76.
5. Govaert TM, Thijis CT, Masurel N, et al.: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
6. Vu T, Farish S, Jenkins M, Kelly H: A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836.
7. Gross PA, Hermogenes AW, Sacks HS, et al.: The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527.
8. Hak E, Nordin J, Wei E et al.: Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002, 35:370-377.
9. Wang CS, Wang ST, Lai CT, et al.: Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004, 39:1604-1610.
10. Collins SD: Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Report (Wash) 1932, 47:2159-2179.
11. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease. Circulation 2003, 108:2730-2736.
12. Naghavi M, Barlas Z, Siadaty S, et al.: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102:3039-3045.
13. Siscovick DS, Raghunathan TE, Lin D, et al.: Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000, 152:674-677.
14. Lavallee P, Perchaud V, Gautier-Bertrand M, et al.: Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513-518.
15. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B: Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. One-year follow-up. Eur Heart J 2004, 25:25-31.
16. Nichol KL, Nordin J, Mullooly J, et al.: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322-1332.
17. Nichol KL, Baken L, Nelson A: Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999, 130:397-403.
18. Wongsurakiat P, Maranetra KN, Wasi C, et al.: Acute respiratory illness in patients with COPD and effectiveness of influenza vaccination. A randomized controlled study. Chest 2004, 125:2011-2020.
19. Nguyen-Van-Tam JS, Nicholson KG: Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season. Epidemiol Infect 1993, 111:347-355.
20. Rothbarth PH, Kempen BM, Sprenger MJ: Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 151:1682-1686.
21. Tata LJ, West J, Harrison T, et al.: Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003, 58:835-839.
22. Betts RF, Treanor JJ: Approaches to improved influenza vaccination. Vaccine 2000, 18:1690-1695.
23. Treanor JJ, Mattison HR, Dumyati G, et al.: Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992, 117:625-633.
24. Gorse GJ, O'Connor TZ, Young SL, et al.: Efficacy of live, cold adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003, 21:2133-2144.
25. Postma MJ, Baltussen RM, Heijnen MA, et al.: Pharmacoeconomics of influenza in the elderly. Reviewing the available evidence. Drugs Aging 2000, 17:217-227.
26. Nichol KL Goodman M: Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine 2002, 20:S21-S24.